| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |






*Department of Pediatrics, University of California at San Diego, California;
Department of Internal Medicine University of Manitoba, Winnipeg, Manitoba; and Departments of
Pathology and
Immunology, University of Calgary, Calgary, Alberta.
Correspondence to Dr. Paul C. Grimm, Division of Pediatric Nephrology, University of California at San Diego, 9500 Gilman Dr. Mail Code 0831, La Jolla, CA 92093-0831. Phone: 619-543-5218; Fax: 619-543-3575;
ABSTRACT. Chronic allograft nephropathy (CAN) is a major problem in posttransplant management. The lack of a reliable and early surrogate marker of CAN has hampered patient care and research. In this study, the Cortical Fractional Interstitial Fibrosis Volume (VIntFib), quantitated with computerized image analysis of Sirius Redstained protocol biopsies, was examined as a potential surrogate for time to graft failure (TTGF) in 68 renal allograft recipients. At 6 mo posttransplant, VIntFib was highly correlated with TTGF (r = 0.64, P < 0.001). Both the Banff Chronic Sum and the Acute Sum Scores were also correlated with TTGF, but less strongly (r = 0.28, P < 0.02; r = 0.35, P < 0.003, respectively). As VIntFib was not correlated with the Banff Chronic Score, a multivariate model was created that incorporated VIntFib and both Acute and Chronic Banff pathology. This model was highly correlated with TTGF (r = 0.7, P < 0.0001). These findings suggest that VIntFib determined by computerized image analysis of Sirius Redstained protocol biopsies at 6 mo posttransplant, with or without incorporation of Banff acute and chronic scoring, may provide an early surrogate for time to graft failure in renal allograft recipients. E-mail: pgrimm@ucsd.edu
This article has been cited by other articles:
![]() |
C. Doucet, S. Milin, F. Favreau, T. Desurmont, E. Manguy, W. Hebrard, Y. Yamamoto, G. Mauco, M. Eugene, V. Papadopoulos, et al. A p38 mitogen-activated protein kinase inhibitor protects against renal damage in a non-heart-beating donor model Am J Physiol Renal Physiol, July 1, 2008; 295(1): F179 - F191. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, J. T. Norman, S. Shrivastav, J. Lucio-Cazana, and J. B. Kopp In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents Am J Physiol Renal Physiol, August 1, 2007; 293(2): F631 - F640. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kambham, S. Nagarajan, S. Shah, L. Li, O. Salvatierra, and M. M. Sarwal A Novel, Semiquantitative, Clinically Correlated Calcineurin Inhibitor Toxicity Score for Renal Allograft Biopsies Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Scholten, A. T. Rowshani, S. Cremers, F. J. Bemelman, M. Eikmans, E. van Kan, M. J. Mallat, S. Florquin, J. Surachno, I. J. ten Berge, et al. Untreated Rejection in 6-Month Protocol Biopsies Is Not Associated with Fibrosis in Serial Biopsies or with Loss of Graft Function J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2622 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Roos-van Groningen, E. M. Scholten, P. M. Lelieveld, A. T. Rowshani, H. J. Baelde, I. M. Bajema, S. Florquin, F. J. Bemelman, E. de Heer, J. W. de Fijter, et al. Molecular Comparison of Calcineurin Inhibitor-Induced Fibrogenic Responses in Protocol Renal Transplant Biopsies J. Am. Soc. Nephrol., March 1, 2006; 17(3): 881 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rush Protocol Transplant Biopsies: An Underutilized Tool in Kidney Transplantation Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 138 - 143. [Full Text] [PDF] |
||||
![]() |
A. T. Rowshani, E. M. Scholten, F. Bemelman, M. Eikmans, M. Idu, M. C.R. van Groningen, J. S. Surachno, M. J.K. Mallat, L. C. Paul, J. W. de Fijter, et al. No Difference in Degree of Interstitial Sirius Red-Stained Area in Serial Biopsies from Area under Concentration-over-Time Curves-Guided Cyclosporine versus Tacrolimus-Treated Renal Transplant Recipients at One Year J. Am. Soc. Nephrol., January 1, 2006; 17(1): 305 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Sis, S Sarioglu, S Sokmen, M Sakar, A Kupelioglu, and M Fuzun Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma J. Clin. Pathol., January 1, 2005; 58(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sund, P. Grimm, A. V. Reisaeter, and T. Hovig Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2838 - 2845. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. Siegel, P. Kossmehl, M. Planert, A. Schulz, M. Wehland, M. Stoll, J. A. Bruijn, E. de Heer, and R. Kreutz Genetic linkage of albuminuria and renal injury in Dahl salt-sensitive rats on a high-salt diet: comparison with spontaneously hypertensive rats Physiol Genomics, July 8, 2004; 18(2): 218 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Giraudeau, J.-M. Halimi, S. J. Jay, L. Pape, G. Offner, J. H.H. Ehrich, J. Radermacher, S. Stuht, and H. Haller Renal Arterial Resistance Index N. Engl. J. Med., October 16, 2003; 349(16): 1573 - 1574. [Full Text] [PDF] |
||||
![]() |
P. A. Marsden Predicting Outcomes after Renal Transplantation -- New Tools and Old Tools N. Engl. J. Med., July 10, 2003; 349(2): 182 - 184. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673